Tavio Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-205,682
Closed -$29.9M 10
2019
Q4
$29.9M Sell
205,682
-22,364
-10% -$3.23M 11.02% 5
2019
Q3
$32.9M Buy
228,046
+20,376
+10% +$2.97M 17.4% 2
2019
Q2
$30.8M Sell
207,670
-153,787
-43% -$21.5M 12.52% 4
2019
Q1
$47.5M Buy
361,457
+213,656
+145% +$26.3M 17.51% 2
2018
Q4
$16M Buy
147,801
+113,681
+333% +$15.2M 6.66% 7
2018
Q3
$5.09M Buy
+34,120
New +$5.19M 1.99% 16

Other funds holding LH

Tavio Capital's LH Position: Q1 2020 in Review

Tavio Capital sold out of Labcorp (LH) in Q1 2020, closing a stake of 205,682 shares — an estimated $29.9M sold.

Tavio Capital first reported a position in LH in Q3 2018 and held it in 6 quarters. The position peaked at $47.5M in Q1 2019. 760 funds tracked by Wall St. Rank hold LH as of Q1 2020.

  • Tavio Capital reported no remaining Labcorp position as of Q1 2020 after selling out during the quarter.
  • Tavio Capital sold 205,682 Labcorp shares in Q1 2020, an estimated $29.9M.
  • Tavio Capital first reported a position in Labcorp in Q3 2018 and held it in 6 quarters.
  • Tavio Capital's Labcorp position peaked at $47.5M in Q1 2019.
  • 760 funds tracked by Wall St. Rank held Labcorp as of Q1 2020.

Based on Tavio Capital's 13F filing for Q1 2020, filed 14 May 2020.